The bare lymphocyte syndrome: Molecular clues to the transcriptional regulation of major histocompatibility complex class II genes

American Journal of Human Genetics

Volumn 65, Issue 2, 1999, Pages 279-286

  DeSandro, Angela ^a   Nagarajan, Uma M ^a   Boss, Jeremy M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

BARE LYMPHOCYTE SYNDROME; CONTROLLED STUDY; DNA SEQUENCE; GENE EXPRESSION REGULATION; GENETIC COMPLEMENTATION; GENOTYPE; HUMAN; HUMAN CELL; IMMUNOGENETICS; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; REVIEW; TRANSCRIPTION REGULATION;

EID: 0033361764     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/302519     Document Type: Article

References (41)

1. Benichou B, Strominger JI. (1991) Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis. Proc Natl Acad Sci USA 88:4285-14288
2. Bontron S, Steimle V, Ucla C, Eibl MM, Mach B (1997) Two novel mutations in the MHC class II transactivator CIITA in a second patient from MHC class II deficiency complementation group A. Hum Genet 99:541-546
3. Boss JM (1997) Regulation of transcription of MHC class II genes. Curr Opin Immunol 9:107-113
4. Brown JA, He X-F, Westerheide SD, Boss JM (1995) Characterization of the expressed CIITA allele in the class II MHC transcriptional mutant RJ2.2.5. Immunogenetics 43:88-91
5. Chang C-H, Fodor WL, Flavell RA (1992) Reactivation of a major histocompatibility complex class II gene in mouse plasmacytoma cells and mouse T cells. J Exp Med 176: 1465-1469
6. Chang C-H, Guerder S, Hong S-C, Van Ewijk W, Flavell RA (1996) Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 4:167-178
7. Clausen BE, Waldburger JM, Schwenk F, Barras E, Mach B, Rajewsky K, Forster I, et al (1998) Residual MHC class II expression on mature dendritic cells and activated B cells in RFX5-deficient mice. Immunity 8:143-155
8. Cressman DE, Chin KC, Taxman DJ, Ting JP (1999) A defect in the nuclear translocation of CIITA causes a form of type II bare lymphocyte syndrome. Immunity 10:163-171
9. Denzin LK, Cresswell P (1995) HLA-DM induces CLIP dissociation from MHC class II α β dimers and facilitates peptide loading. Cell 82:155-165
10. de Preval C, Lisowska-Grospierre B, Loche M, Griscelli C, Mach B (1985) A trans-acting class II regulatory gene unlinked to the MHC controls expression of HLA class II genes. Nature 318:291-293
11. Durand B, Sperisen P, Emery P, Barras E, Zufferey M, Mach B, Reith W (1997) RFXAP, a novel subunit of the RFX DNA binding complex, is mutated in MHC class II deficiency. EMBO J 16:1045-1055
12. Elhasid R, Etzioni A (1996) Major histocompatibility complex class II deficiency: a clinical review. Blood Rev 10:242-248
13. Fondaneche M, Villard J, Wiszniewski W, Jouanguy E, Etzioni A, Le Deist F, Peijnenburg A, et al (1998) Genetic and molecular definition of complementation group D in MHC class II deficiency. Hum Mol Gen 7:879-885
14. Fontes JD, Kanazawa S, Jean D, Peterlin BM (1999) Interactions between the class II transactivator and CREB binding protein increase transcription of major histocompatibility complex class II genes. Mol Cell Biol 19:941-947
15. Gladstone P, Pious D (1978) Stable variants affecting B cell alloantigens in human lymphoid cells. Nature 271:459-461
16. -(1980) Identification of a trans-acting function regulation HLA-DR expression in a DR-negative B cell variant. Somat Cell Genet 6:285-298
17. Gobin SJP, Peijnenburg A, Keijsers V, van den Elsen PJ (1997) Site α is crucial for two routes of IFNγ-induced MHC class I transactivation: The ISRE-mediate route and a novel pathway involving CIITA. Immunity 6:601-611
18. Gobin SJP, Peijneburg A, van Eggermond M, van Zutphen M, van den Berg R, van den Elsen P (1998) The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and beta 2-microglobulin genes. Immunity 9:531-541
19. Griscelli C, Lisowska-Grospierre B, Mach B (1989) Combined immunodeficiency with defective expression in MHC class II genes. Immunodefic Rev 1:135-153
20. Kara CJ, Glimcher LH (1991) In vivo footprinting of MHC class II genes: bare promoters in the bare lymphocyte syndrome. Science 252:709-712
21. -(1993) Developmental and cytokine-mediated regulation of MHC class II gene promoter occupancy in vivo. J Immunol 150:4934-4942
22. Klein C, Lisowska-Grospierre B, LeDeist F, Fischer A, Griscelli C (1993) Major histocompatibility complex class II deficiency: Clinical manifestations, immunologic features, and outcome. J Pediatr 123:921-928
23. Kretsovali A, Agaloti T, Spilianakis C, Tzortzakaki E, Merika M, Papamatheakis J (1998) Involvement of CREB binding protein in expression of major histocompatibility complex class II genes via interaction with the class II transactivator. Mol Cell Biol 18:6777-6783
24. Martin BK, Chin K-C, Olsen JC, Skinner CA, Dey A, Ozato K, Ting JP-Y (1997) Induction of MHC class I expression by the MHC class II transactivator CIITA. Immunity 6: 591-600
25. Masternak K, Barras E, Zufferey M, Conrad B, Corthals G, Aebersold R, Sanchez J-C, et al (1998) A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients. Nat Genet 20: 273-277
26. Moreno CS, Beresford G, Louis-Plence P, Morris AC, Boss JM (1999) CREB regulates MHC class II expression in a CIITA-dependent manner. Immunity 10:143-151
27. Moreno CS, Rogers EM, Brown JA, Boss JM (1997) RFX, a bare lymphocyte syndrome transcription factor, is a multimeric phosphoprotein complex. J Immunol 158:5841-5848
28. Nagarajan UM, Louis-Plence P, DeSandro A, Nilsen R, Bushey A, Boss JM (1999) RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, a MHC class II immunodeficiency. Immunity 10:153-162
29. Peijnenburg A, van Eggermond MCJA, van den Berg R, Sanal O, Vossen JMJJ, van den Elsen PJ (1999) Molecular analysis of an MHC class II deficiency patient reveals a novel mutation in the RFX5 gene. Immunogenetics 49:338-345
30. Peters PJ, Neefjes JJ, Oorschot V, Ploegh HL, Geuze HJ (1991) Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature 349:669-676
31. Riley JL, Westerheide SD, Price JA, Brown JA, Boss JM (1995) Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). Immunity 2: 533-543
32. Seidl C, Saraiya C, Osterweil Z, Fu YP, Lee JS (1992) Genetic complexity of regulatory mutants defective for HLA class II expression. J Immunol 148:1576-1584
33. Steimle V, Durand B, Emmanuele B, Zufferey M, Hadam MR, Mach B, Reith W (1995) A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev 9:1021-1032
34. Steimle V, Otten LA, Zufferey M, Mach B (1993) Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135-146
35. Steimle V, Siegrist C-A, Mottet A, Lisowska-Grospierre B, Mach B (1994) Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 265:106-108
36. Villard J, Lisowska-Grospierre B, van den Elsen P, Fischer A, Reith W, Mach B (1997a) Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiency. N Engl J Med 337:748-753
37. Villard J, Reith W, Barras E, Gos A, Morris MA, Antonarakis Sa E, van den Elsen PJ, et al (1997b) Analysis of mutations and chromosomal localisation of the gene encoding RFX5, a novel transcription factor affected in major histocompatibility complex class II deficiency. Hum Mutat 10:430-435
38. Westerheide SD, Boss JM (1999) Site-specific crosslinking mapping of RFX and X2BP transcription factor subunits to the major histocompatibility complex class II transcriptional enhancer. Nucleic Acids Res 27:1635-1641
39. Williams GS, Malin M, Vremec D, Chang C-H, Boyd R, Benoist C, Mathis D (1998) Mice lacking the transcription factor CIITA-a second look. Int Immunol 10:1957-1967
40. Wright KL, Chin K-C, Linhoff M, Skinner C, Li G, Boss JM, Stark GR, et al (1998) CIITA stimulation of transcription factor binding to major histocompatibility complex class II and associated promoters in vivo. Proc Natl Acad Sci USA 95:6267-6272
41. Zhou H, Glimcher LH (1995) Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity 2:545-553